Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
. (2020) ALSUntangled No. 54: “LEAP2BFIT”. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 314-319.
Read now
Read now
Articles from other publishers (21)
Michael Kunle Ajenikoko, Abayomi Oyeyemi Ajagbe, Oluwanisola Akanji Onigbinde, Akeem Ayodeji Okesina & Ahmad Adekilekun Tijani. (2023) Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction. IBRO Neuroscience Reports 14, pages 64-76.
Crossref
Crossref
Urna Kansakar, Valentina Trimarco, Pasquale Mone, Fahimeh Varzideh, Angela Lombardi & Gaetano Santulli. (2023) Choline supplements: An update. Frontiers in Endocrinology 14.
Crossref
Crossref
Getu Gamo Sagaro, Enea Traini & Francesco Amenta. (2023) Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis. Journal of Alzheimer's Disease 92:1, pages 59-70.
Crossref
Crossref
E. V. Ponomareva. (2023) The Effectiveness of Choline Alfoscerate in the Treatment of Patients with Amnestic Mild Cognitive Impairment: A Comparative Prospective Study. Psikhiatriya 21:1, pages 62-72.
Crossref
Crossref
V. A. Parfenov. (2023) Management of patients with cognitive impairment. Neurology, Neuropsychiatry, Psychosomatics 15:1, pages 97-102.
Crossref
Crossref
Ha-Ri Kim, Hee-Yeon Shin, Tae-Bin Yim, Geon-Ho Jahng, Chul Jin, Seungwon Kwon, Seung-Yeon Cho, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Chang-Nam Ko & Jung-Mi Park. (2023) Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer’s Disease: A Pilot Study. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-15.
Crossref
Crossref
E.G. Mendelevich. (2022) Chronic cerebral ischemia and dizziness. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 122:3, pages 22.
Crossref
Crossref
D. V. Zakharov & Y. V. Buriak. (2021) The Post-COVID-19 cognitive impairment. A modern view of the problem, pathogenesis and treatment. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 57:4, pages 97-105.
Crossref
Crossref
Jin-Sun Hwang & Young-Joo Shin. (2021) Role of Choline in Ocular Diseases. International Journal of Molecular Sciences 22:9, pages 4733.
Crossref
Crossref
Chiara Burgaletto, Giulia Di Benedetto, Antonio Munafò, Renato Bernardini & Giuseppina Cantarella. (2021) Beneficial Effects of Choline Alphoscerate on Amyloid-β Neurotoxicity in an In vitro Model of Alzheimer’s Disease. Current Alzheimer Research 18:4, pages 298-309.
Crossref
Crossref
Jin Ju Choi, Jin Sun Hwang & Young Joo Shin. (2020) Effect of Oral Choline Alfoscerate on Patients with Keratoconjunctivitis Sicca. Nutrients 12:5, pages 1526.
Crossref
Crossref
Bomin Kim, Hee-Geun Jo, Hyung-Won Kang, Sung-Youl Choi, Min-Yeong Song, Jae-Uk Sul & Jungtae Leem. (2019) Proposal of Evidence-based East-West Integrative Medicine Manual for Vascular Dementia. Journal of Korean Medicine 40:1, pages 46-62.
Crossref
Crossref
A. V. Alesenko, S. I. Gavrilova, U. A. Gutner, A. O. Lebedeva, M. A. Shupik, I. V. Kolykhalov, E. V. Ponomareva, N. D. Selezneva & Ya. B. Fedorova. (2018) Studies of the Efficacy of Cereton in Mild Cognitive Impairment of the Amnestic Type Based on Testing Lipid Markers. Neuroscience and Behavioral Physiology 49:1, pages 147-152.
Crossref
Crossref
HyunChul Youn & Hyun-Ghang Jeong. (2018) Pharmacotherapy for dementia. Journal of the Korean Medical Association 61:12, pages 758.
Crossref
Crossref
S. I. Gavrilova, I. V. Kolykhalov, E. V. Ponomareva, Ya. B. Fedorova & N. D. Selezneva. (2018) Clinical efficacy and safety of choline alfoscerate in the treatment of late-onset cognitive impairment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:5, pages 45.
Crossref
Crossref
A. V. Alesenko, S. I. Gavrilova, U. A. Gutner, A. O. Lebedeva, M. A. Shupik, I. V. Kolykhalov, E. V. Ponomareva, N. D. Selezneva & Ya. B. Fedorova. (2017) Detection of effective treatment of amnestic mild cognitive impairement with cereton by testing of lipids markers. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:6, pages 21.
Crossref
Crossref
Gerda Strifler, Eszter Tuboly, Anikó Görbe, Mihály Boros, Daniella Pécz & Petra Hartmann. (2016) Targeting Mitochondrial Dysfunction with L-Alpha Glycerylphosphorylcholine. PLOS ONE 11:11, pages e0166682.
Crossref
Crossref
D. P. Lippelt, S. van der Kint, K. van Herk & M. Naber. (2016) No Acute Effects of Choline Bitartrate Food Supplements on Memory in Healthy, Young, Human Adults. PLOS ONE 11:6, pages e0157714.
Crossref
Crossref
E. Yu. Solov’eva, E. D. Dzhutova & V. S. Knyazeva. (2016) Pathogenetic approaches to treatment of cognitive disorders in patients with diabetes mellitus. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:7, pages 85.
Crossref
Crossref
Marnix Naber, Bernhard Hommel & Lorenza S. Colzato. (2015) Improved human visuomotor performance and pupil constriction after choline supplementation in a placebo-controlled double-blind study. Scientific Reports 5:1.
Crossref
Crossref
Carlos Nicolás, Mónica Calvo-Polanco, Jorge Poveda, Ana Alonso-Ramírez, Vicent Arbona, Rosa Hermosa & Enrique Monte. (2021) Rapeseed Overexpressing the <i>Trichoderma Thkel1</i> Gene Can Be Colonized by Arbuscular Mycorrhizal Fungi With Increases in Seed Yield and Oil Quality. SSRN Electronic Journal.
Crossref
Crossref